文献速递关节外科

门诊关节置换在门诊手术中心与医院门诊部的90天结局相当

Comparable Outcomes of Total Joint Arthroplasty Performed at Ambulatory Surgery Centers and Hospital Outpatient Departments.
PubMed 文献 · J Arthroplasty · 2026-03-13

本研究回顾性比较单中心2016年6月至2024年4月初次门诊全关节置换患者,ASC组615例与HOPD组624例,随访至少90天。调整性别、BMI、Charlson合并症指数和手术类型后,两组医疗并发症、手术并发症、假体周围感染、伤口并发症、再入院、翻修及再手术率均无显著差异。结论认为门诊关节置换在ASC与HOPD的90天结局相当,再次证实其安全性。

要点

  • ASC与HOPD的门诊全关节置换90天医疗和手术并发症率无显著差异。
  • 假体周围感染、伤口并发症、再入院、翻修及再手术率在两组间均无统计学差异。
  • ASC组任何并发症有降低趋势(4.6% vs 6.7%,OR 0.61,P=0.061),但未达统计学显著。

核心结论

  • 门诊全关节置换在ASC与HOPD的90天结局相当,支持无论门诊场所如何,门诊关节置换均是安全的。

研究设计与样本

  • 单中心回顾性队列研究,纳入2016年6月至2024年4月初次全关节置换且随访至少90天的患者,ASC组615例(49.6%),HOPD组624例(50.4%)。

主要发现

  • 医疗并发症发生率ASC 1.1% vs HOPD 1.9%(OR 0.55,P=0.230),手术并发症3.3% vs 2.9%(OR 1.01,P=0.977)。
  • 假体周围感染ASC 0.8% vs HOPD 0.5%(OR 1.25,P=0.770),伤口并发症1.8% vs 2.0%(OR 0.72,P=0.458)。
  • 90天再入院ASC 2.8% vs HOPD 4.0%(OR 0.66,P=0.356),翻修1.0% vs 1.0%(OR 0.77,P=0.674),再手术1.6% vs 2.6%(OR 0.55,P=0.163)。
  • 任何并发症ASC 4.6% vs HOPD 6.7%(OR 0.61,P=0.061),差异无统计学意义。

关键数值与推荐

  • 多因素logistic回归调整性别、BMI、Charlson合并症指数和手术类型,并对稀有事件采用Firth校正。

临床怎么用

  • 在并发症低且相当的前提下,选择ASC或HOPD可综合考虑设施成本和患者偏好等因素。

局限性

  • 单中心回顾性设计,样本量可能不足以检测任何并发症的显著差异(P=0.061)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the volume of outpatient total joint arthroplasty (TJA) continues to rise, evaluating outcomes across surgical settings has become increasingly important. Our study compared rates of 90-day complications between patients undergoing outpatient TJA at an ambulatory surgery center (ASC) and a hospital outpatient department (HOPD). METHODS: Patients undergoing primary TJA at a single institution between June 2016 and April 2024 with a minimum of 90-day follow-up were retrospectively identified (ASC: n = 615, 49.6%; HOPD: n = 624; 50.4%). Demographics and 90-day outcomes, including complications, readmissions, and reoperations, were documented. Univariate and multivariate logistic regressions, including Firth's correction for scarce events, were performed for all evaluated outcomes while adjusting for sex, body mass index, Charlson Comorbidity Index, and procedure type. RESULTS: The incidence of medical (1.1 versus 1.9%; odds ratio (OR) 0.55; P = 0.230) and surgical complications (3.3 versus 2.9%; OR 1.01; P = 0.977) were comparable between the ASC and HOPD cohorts, respectively. Specifically, the risk of periprosthetic joint infection (ASC: 0.8% versus HOPD: 0.5%; OR 1.25; P = 0.770), wound complications (1.8 versus 2.0%, OR 0.72; P = 0.458), and 90-day readmission (2.8 versus 4.0%; OR 0.66; P = 0.356) were not significantly different. Similarly, there were no differences in the incidence of 90-day revision (1.0 versus 1.0%; OR 0.77; P = 0.674) or reoperation (1.6 versus 2.6%; OR 0.55; P = 0.163) between surgical settings. Although there was a trend toward ASC patients having a lower risk of any complication at 90 days (4.6 versus 6.7%; OR 0.61; P = 0.061), this finding was not statistically significant with the number of patients studied. CONCLUSIONS: The present analysis found comparable 90-day outcomes between patients undergoing outpatient TJA at an ASC and HOPD. These findings reaffirm the safety of outpatient TJA regardless of outpatient setting. In addition, these findings suggest that other factors such as facility costs and patient preference may be considered when determining a surgical setting given comparable low rates of complications.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Potluri AS, Yadav AS, Acuña AJ, et al. Comparable Outcomes of Total Joint Arthroplasty Performed at Ambulatory Surgery Centers and Hospital Outpatient Departments. J Arthroplasty. 2026. PMID: 41833842. doi:10.1016/j.arth.2026.03.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。